Clinical Trials Directory

Trials / Unknown

UnknownNCT04374084

Moxibustion Plus Cupping in Convalescent Patients With COVID-19

Moxibustion Plus Cupping in Convalescent Patients With COVID-19: A Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.

Detailed description

Moxibustion plus cupping may be effective and safe for convalescent patients with COVID-19, but evidence is limited. The randomized clinical trial may help to provide evidence-based factors for improving the patients' symptoms in the convalescence of COVID-19.

Conditions

Interventions

TypeNameDescription
OTHERMoxibustion plus CuppingMoxibustion: The burning of a small, thimble sized, smoldering plug of dried leaves on the skin at an acupuncture point. Usually the plugs contain leaves of mugwort or moxa. Cupping takes the pot as a tool, uses the combustion to remove the air in the pot, causes a negative pressure, and makes it adsorb on the skin of the acupoints. Use"Baixiaojiu"moxibustion on each acupoint for 10-15 minutes, the temperature of moxibustion should be adjusted within patient's tolerance level. Use diameter of 5-6 cm acuum cupper to cupping on each acupoint for 5-8 minutes.

Timeline

Start date
2020-05-10
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2020-05-05
Last updated
2021-11-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04374084. Inclusion in this directory is not an endorsement.